Envoy Medical Inc (COCH)

$0.67 +0.02 (2.29%)
Market Cap 18.86M
Revenue (ttm) 230,000.00
Net Income (ttm) -20.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,043.48%
Debt to Equity Ratio 0.00
Volume 138,400
Avg Vol 299,728
Day's Range N/A - N/A
Shares Out 28.79M
Stochastic %K 33%
Beta 2.11
Analysts Strong Sell
Price Target $7.50

Company Profile

Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy...

Industry: Medical Devices
Sector: Healthcare
Phone: 877 900 3277
Address:
4875 White Bear Parkway, White Bear Lake, United States
OllieOverTheMoon
OllieOverTheMoon Jan. 20 at 6:29 PM
$COCH Just now getting around to seeing that What If video!! Really well done.
0 · Reply
David_M_
David_M_ Jan. 20 at 5:58 PM
$COCH Good news: No announcement of bankruptcy, liquidation, or forced delisting have occurred.
0 · Reply
Stock28
Stock28 Jan. 15 at 4:27 AM
$COCH This can go 100% anytime
1 · Reply
EmielTheBlessed
EmielTheBlessed Jan. 13 at 7:26 PM
$COCH
0 · Reply
Jbganjian123
Jbganjian123 Jan. 13 at 3:35 AM
$COCH Gentlemen, Let’s meme this already.
1 · Reply
BinaryLogic
BinaryLogic Jan. 10 at 9:12 PM
$COCH [Stochastics] Double bottom at/around $0.65, ATL as the Company continues to quietly secure intellectual property and continues its progression on Acclaim study. $16M placement in October, $1.33 strike price not yet reflected in financials. Non-compliance issue with Nasdaq requires resolution. Debt has been eliminated entirely, $20M Cash (appx) against $(15)M Total Liabilities, which equates to a Cash runway of appx 12-15mos. The Company needs a partner agreement (IMO) similar to $RANI. If/where that is secured and the Company regains compliance, multiplier upside (IMO) from this level. Start/Build/Add at $0.65 support line which might see a triple bottom retest. 100% upside to Oct-2025 placement alone.
1 · Reply
BinaryLogic
BinaryLogic Jan. 8 at 1:48 AM
$COCH [Again]
0 · Reply
Tunes444
Tunes444 Jan. 7 at 3:41 PM
$COCH Found these guys from the What If video they did a while back
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 1 at 5:47 AM
$COCH
0 · Reply
Ipleadthe5th
Ipleadthe5th Dec. 31 at 9:08 PM
$COCH
0 · Reply
Latest News on COCH
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Dec 18, 2025, 8:00 AM EST - 5 weeks ago

Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant

Dec 10, 2025, 8:00 AM EST - 6 weeks ago

Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant

Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient

Dec 4, 2025, 8:00 AM EST - 7 weeks ago

Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient

Envoy Medical Announces the Grant of Its 40th U.S. Patent

Dec 2, 2025, 8:00 AM EST - 7 weeks ago

Envoy Medical Announces the Grant of Its 40th U.S. Patent

Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

Nov 20, 2025, 8:00 AM EST - 2 months ago

Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

Nov 10, 2025, 8:00 AM EST - 2 months ago

Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Nov 4, 2025, 8:00 AM EST - 2 months ago

Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant

Oct 29, 2025, 8:00 AM EDT - 3 months ago

Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant

Envoy Medical Receives Positive Listing Determination from NASDAQ

Oct 27, 2025, 8:00 AM EDT - 3 months ago

Envoy Medical Receives Positive Listing Determination from NASDAQ

Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 9, 2025, 4:05 PM EDT - 3 months ago

Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 8, 2025, 7:00 AM EDT - 3 months ago

Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 7, 2025, 8:00 AM EDT - 3 months ago

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 7, 2025, 8:00 AM EDT - 3 months ago

Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th

Oct 1, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th

Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 25, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Sep 24, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 22, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

Sep 19, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

Sep 10, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

Sep 9, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025

Sep 8, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

Sep 3, 2025, 8:00 AM EDT - 5 months ago

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

Aug 26, 2025, 8:00 AM EDT - 5 months ago

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology

Aug 20, 2025, 8:00 AM EDT - 5 months ago

Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology

Envoy Medical Reports on Second Quarter 2025 Results

Jul 31, 2025, 8:00 AM EDT - 6 months ago

Envoy Medical Reports on Second Quarter 2025 Results

Envoy Medical Expands Patent Portfolio with New Issuances in the United States

Jul 8, 2025, 8:00 AM EDT - 7 months ago

Envoy Medical Expands Patent Portfolio with New Issuances in the United States

Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia

Jul 1, 2025, 8:00 AM EDT - 7 months ago

Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia

New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical

Jun 26, 2025, 8:00 AM EDT - 7 months ago

New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical

Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

Jun 11, 2025, 8:30 AM EDT - 8 months ago

Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up

Jun 10, 2025, 8:30 AM EDT - 8 months ago

Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

May 13, 2025, 9:15 AM EDT - 9 months ago

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

Envoy Medical Reports on First Quarter 2025 Results

May 1, 2025, 4:30 PM EDT - 9 months ago

Envoy Medical Reports on First Quarter 2025 Results

EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies

Apr 22, 2025, 6:00 AM EDT - 9 months ago

EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 31, 2025, 9:15 AM EDT - 10 months ago

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Mar 17, 2025, 9:25 AM EDT - 11 months ago

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Mar 12, 2025, 9:00 AM EDT - 11 months ago

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Envoy Medical to Participate in the 37th Annual ROTH Conference

Mar 10, 2025, 9:00 AM EDT - 11 months ago

Envoy Medical to Participate in the 37th Annual ROTH Conference

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Feb 24, 2025, 9:25 AM EST - 11 months ago

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Feb 14, 2025, 9:15 AM EST - 1 year ago

Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Dec 19, 2024, 9:00 AM EST - 1 year ago

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Nov 14, 2024, 8:38 AM EST - 1 year ago

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Envoy Medical's Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Nov 12, 2024, 9:25 AM EST - 1 year ago

Envoy Medical's Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Nov 8, 2024, 9:25 AM EST - 1 year ago

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Envoy Medical to Present at the LD Micro Main Event XVII

Oct 23, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical to Present at the LD Micro Main Event XVII

Major Envoy Medical Investor Glen Taylor Discusses How Apple's AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company

Sep 23, 2024, 8:00 AM EDT - 1 year ago

Major Envoy Medical Investor Glen Taylor Discusses How Apple's AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company

Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Sep 16, 2024, 9:00 AM EDT - 1 year ago

Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying

Sep 12, 2024, 7:19 AM EDT - 1 year ago

Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying

HYLN SXTP

Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update

Aug 12, 2024, 8:34 AM EDT - 1 year ago

Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update

Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage

Jul 31, 2024, 8:00 AM EDT - 1 year ago

Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage

OllieOverTheMoon
OllieOverTheMoon Jan. 20 at 6:29 PM
$COCH Just now getting around to seeing that What If video!! Really well done.
0 · Reply
David_M_
David_M_ Jan. 20 at 5:58 PM
$COCH Good news: No announcement of bankruptcy, liquidation, or forced delisting have occurred.
0 · Reply
Stock28
Stock28 Jan. 15 at 4:27 AM
$COCH This can go 100% anytime
1 · Reply
EmielTheBlessed
EmielTheBlessed Jan. 13 at 7:26 PM
$COCH
0 · Reply
Jbganjian123
Jbganjian123 Jan. 13 at 3:35 AM
$COCH Gentlemen, Let’s meme this already.
1 · Reply
BinaryLogic
BinaryLogic Jan. 10 at 9:12 PM
$COCH [Stochastics] Double bottom at/around $0.65, ATL as the Company continues to quietly secure intellectual property and continues its progression on Acclaim study. $16M placement in October, $1.33 strike price not yet reflected in financials. Non-compliance issue with Nasdaq requires resolution. Debt has been eliminated entirely, $20M Cash (appx) against $(15)M Total Liabilities, which equates to a Cash runway of appx 12-15mos. The Company needs a partner agreement (IMO) similar to $RANI. If/where that is secured and the Company regains compliance, multiplier upside (IMO) from this level. Start/Build/Add at $0.65 support line which might see a triple bottom retest. 100% upside to Oct-2025 placement alone.
1 · Reply
BinaryLogic
BinaryLogic Jan. 8 at 1:48 AM
$COCH [Again]
0 · Reply
Tunes444
Tunes444 Jan. 7 at 3:41 PM
$COCH Found these guys from the What If video they did a while back
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 1 at 5:47 AM
$COCH
0 · Reply
Ipleadthe5th
Ipleadthe5th Dec. 31 at 9:08 PM
$COCH
0 · Reply
frontiere
frontiere Dec. 29 at 9:16 PM
$COCH Envoy Medical ref=$0.70 — Long and adding dips — wow, 8-K put just now very Bullish — the remaining 1,125,499 Meteora wrts exp 2025-12-31 extended to 2026-12-31 with a EP floor still at $1.50!!! 👍👍 Means COCH not desperate to raise here at half of strike and not “restriking” lower, and Meteora also isn’t bearish but is willing to keep exposure at high strike. SEC filing https://www.sec.gov/ix?doc=/Archives/edgar/data/0001840877/000121390025126032/ea0270888-8k_envoy.htm
0 · Reply
VicAge
VicAge Dec. 29 at 6:20 PM
$COCH tax loss harvesting once it is over we should move into the dollars
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 26 at 10:07 PM
$COCH RSI: 34.70, MACD: -0.0205 Vol: 0.06, MA20: 0.78, MA50: 0.77 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
LockpickingLord
LockpickingLord Dec. 26 at 1:37 PM
$COCH Risk appetite is present but conditioned on validation. Cash efficiency must trend upward while maintaining strategic flexibility. Transparency improvements could narrow valuation discounts. Without validation, volatility will remain persistent.
0 · Reply
joshszary
joshszary Dec. 24 at 4:40 PM
$COCH Started a position here yesterday
0 · Reply
VicAge
VicAge Dec. 23 at 2:52 PM
$COCH MMs are scratching for volume . . . even on the drops. Need a good catalysts or a some big pharma mojo
0 · Reply
Random123456
Random123456 Dec. 21 at 6:44 PM
$COCH has anyone done an analysis on the future earnings here? How many surgeries do they estimate being able to perform each year and at what wholesale device cost? The numbers have the potential to be massive.
1 · Reply
nowOrNever1
nowOrNever1 Dec. 20 at 6:01 PM
$COCH please be the daily candle the bulls have been waiting for! Hammer ✔️ double bottom ✔️ macd ✔️ 100% is at gap fill from the recent low! Lets get it! $SCNX gonna ride with it!
1 · Reply
VicAge
VicAge Dec. 19 at 6:09 PM
$COCH Patent cliff coming for some big pharma players, this one should be on their radar for buyout.
0 · Reply
newsfile_corp
newsfile_corp Dec. 18 at 1:02 PM
https://nfne.ws/278490 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #NASDAQ #Investing
0 · Reply
Stock_Catcher
Stock_Catcher Dec. 18 at 1:02 PM
$COCH Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
0 · Reply
VishalMathew
VishalMathew Dec. 18 at 1:12 AM
$COCH Fireside chat is available now https://ir.envoymedical.com/_assets/_b7edd94a33439c6b9e98401febe2c857/envoymedical/files/53a3857c73c2ed49eb7ba66d239c97f2.mp4
0 · Reply